Periolimel 2.5% E 0.42 g (Tryptophan EMULSION) 0.42 G

Periolimel 2.5% E 0.42 G is an intravenous emulsion containing tryptophan, used for nutritional support. This product by Baxter Corporation helps meet dietary needs in clinical settings.

Strength

0.42 G

Pack Size

1000/1500/2000/2500ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Periolimel 2.5% E 0.42 G is primarily used for intravenous nutritional support. It provides essential amino acids, including tryptophan, to support protein synthesis and overall health. This emulsion is often used in clinical settings where oral nutrition is insufficient or not possible.

Side Effects

When administered intravenously, Periolimel 2.5% E 0.42 G provides essential nutrients directly into the bloodstream. This can help maintain or improve nutritional status in patients who require intravenous nutrition. Common effects include improved energy levels and support for tissue repair.

Precautions & Warnings

Periolimel 2.5% E 0.42 G should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure the emulsion remains stable. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

Periolimel 2.5% E 0.42 G may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain medications that affect liver function may influence the effectiveness of this emulsion.

Frequently Asked Questions

Periolimel 2.5% E 0.42 G is used for intravenous nutritional support, providing essential amino acids like tryptophan to support protein synthesis and overall health.

Periolimel 2.5% E 0.42 G is administered intravenously, typically in a clinical setting under medical supervision.

Common effects include improved energy levels and support for tissue repair, as it provides essential nutrients directly into the bloodstream.

Yes, it should be administered under medical supervision and proper handling and storage guidelines should be followed to ensure stability.

Yes, it may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.